LONDON, RESEARCH TRIANGLE PARK, N.C., and MISSISSAUGA, Ontario, Dec. 1 /PRNewswire-FirstCall/ — GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced receipt of a Complete Response letter from the U.S. Food and Drug…
Read this article:
GSK and Valeant Announce Receipt of U.S. FDA Complete Response Letter for ezogabine